VIC TAC medication rules and guidelines

Expert overview of medication governance in Victorian motor accident claims for professional insurers

Published 3 April 2026

Introduction

Victoria's motor accident insurance scheme is administered by the Transport Accident Commission (TAC), operating under the Transport Accident Act 1986 (Vic). TAC claims involve complex medication management challenges, as motor accident injuries frequently result in acute pain, functional limitation, and comorbid psychological conditions requiring integrated pharmacological and non-pharmacological treatment. For professional indemnity insurers and claims managers operating in Victoria, understanding TAC medication governance requirements is essential to managing claims effectively and supporting better claimant outcomes.

This article provides a specialist overview of medication rules and governance frameworks applicable to TAC claims in Victoria.

Legislative and Regulatory Framework

The Transport Accident Act 1986 (Vic) establishes the legal framework for TAC claims. Treatment expenses, including medications, are covered under TAC's "reasonable and necessary treatment" framework. A treatment is considered reasonable and necessary where it is:

• Clinically appropriate for the accepted injury or condition.
• Evidence-based and aligned with established clinical guidelines.
• Delivered by an appropriately qualified and authorized provider.
• Reasonably expected to benefit the claimant's recovery and functional capacity.

TAC policy and guidance documents provide additional information on treatment authorization and assessment. While TAC does not issue detailed medication-specific protocols, the reasonable and necessary test is the primary framework for assessing medication coverage.

TAC Treatment Authorization and Medication Assessment

TAC requires that certain treatments be authorized or approved before provision. While many medications are prescribed without formal TAC authorization, insurers managing claims should expect that medication prescribing is appropriately documented and clinically justified. For complex medication scenarios, insurers may seek clarification from treating practitioners regarding clinical justification for continued therapy.

Prescribing Standards and Evidence-Based Practice

Prescribers in Victoria follow the Therapeutic Guidelines and the Australian Medicines Handbook as primary references for evidence-based prescribing. Motor accident claimants frequently require pain management, psychological support, and restoration of function. Best practice medication governance in TAC claims requires attention to several specific medication categories.

Acute and Chronic Pain Management

Pain management is a central issue in motor accident claims. Current best practice emphasizes multimodal pain management combining physical therapy, psychological interventions, and appropriately selected pharmacological therapy. For analgesic prescribing in TAC claims:

• Initial pain management should prioritize non-opioid analgesics (paracetamol, NSAIDs) where clinically appropriate.
• Opioid prescribing should be applied cautiously, with documented clinical justification and clear timeframes for review and deprescribing.
• Analgesic therapy should be integrated with rehabilitation and mobilization to support functional recovery.
• Long-term analgesic therapy should be reviewed regularly, with assessment of continued necessity and efficacy.

Motor accident injuries typically show functional improvement over a 12-month period. Prolonged analgesic prescribing, particularly opioid therapy, extending significantly beyond this timeframe may warrant insurer review and consideration of independent medication assessment.

Muscle Relaxants and Spasticity Management

Muscle relaxants such as diazepam and other benzodiazepines are sometimes prescribed for acute muscle spasm following motor accident injury. However, current guidelines recommend limiting benzodiazepine prescribing to short-term use (typically 2-4 weeks) due to dependence risk and impact on rehabilitation. Alternative approaches such as physiotherapy and exercise-based interventions should be prioritized.

Psychological and Psychiatric Medications

Motor accident injury frequently results in mood disturbance, anxiety, or post-traumatic stress. Selective serotonin reuptake inhibitors (SSRIs) are considered first-line pharmacological treatment. Psychological interventions such as cognitive-behavioral therapy should be integrated with pharmacological treatment. TAC typically funds psychological services alongside medications, supporting integrated mental health treatment.

Benzodiazepine and Z-Drug Governance

Benzodiazepines and related Z-drugs warrant particular attention in TAC claims governance. These medications carry significant dependence risk and may impair functional recovery in motor accident claimants. Best practice includes:

• Time-limited prescribing (2-4 weeks maximum) with explicit deprescribing plan documented.
• Regular clinical review by the prescriber, particularly where the initial prescription period is exceeded.
• Consideration of alternative interventions including psychological therapy and sleep hygiene support.
• Documentation of dependence risk assessment, particularly for claimants with personal or family history of substance use disorder.

Pharmacy Services and Medication Access

Community pharmacists in Victoria provide important medication counseling and support services for TAC claimants. Key pharmacy services relevant to TAC claims include:

Insurers managing TAC claims may benefit from engaging pharmacy services in scenarios including:

• Complex polypharmacy requiring rationalization or deprescribing.
• Long-term medication use extending beyond typical motor accident recovery timeframes.
• Benzodiazepine or opioid dependence risk requiring deprescribing support.
• Medication-related functional impairment affecting rehabilitation progress.

Scheduling and Controlled Substance Prescribing

Victoria uses the Australian Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP) to classify medications. Schedule 8 substances (controlled drugs) include opioids and other medications subject to strict regulatory requirements. In TAC claims, Schedule 8 prescribing should be:

• Time-limited with clear clinical documentation of indication and justification.
• Subject to regular review by the prescriber, with assessment of continued necessity.
• Accompanied by risk screening for dependence, particularly for claimants with personal or family history of substance use.
• Integrated with physical rehabilitation to support functional recovery.

Return to Work and Medication Considerations

A key objective of TAC claims management is supporting claimants to return to work. Medication selection and management should be considered in relation to functional capacity and work feasibility. Medications affecting alertness, cognition, or motor function may impact return-to-work capability, particularly in safety-critical or cognitively demanding roles.

Insurers should expect treating practitioners to document:

• Functional impact of medications, particularly effects on alertness, cognition, or motor function.
• Consideration of medication adjustments where functional impairment affects work capacity.
• Coordination between medication management and work capacity assessment.
• Regular review of medication necessity as functional capacity improves.

Independent Medication Review in TAC Claims

Independent medication reviews by specialist pharmacists can provide valuable insight into medication appropriateness, dependence risk, and functional implications in complex TAC claims. Medication reviews are particularly valuable where:

• Complex polypharmacy requires rationalization.
• Prolonged opioid or benzodiazepine prescribing extends beyond typical recovery timeframes.
• Medication-related functional impairment affects return to work.
• Disputes arise regarding medication necessity or appropriateness.
• Transition to long-term medication management requires specialist assessment.

Best Practice for TAC Claims Management

For insurers managing TAC claims, best practice medication governance should include:

• Early assessment: Review medication profile in early claims to identify concerning patterns or emerging polypharmacy issues.
• Documentation: Maintain clear records of all medication-related communications and clinical reasoning for decisions.
• Rehabilitation coordination: Ensure medication management is aligned with rehabilitation planning and return-to-work objectives.
• Specialist consultation: Engage pain specialists, psychiatrists, or other medical specialists for complex medication scenarios.
• Regular review: Establish regular review protocols for long-term medication use, particularly Schedule 8 substances.

Emerging Issues and Future Developments

Victoria's motor accident treatment landscape continues to evolve, with increasing emphasis on integrated care, early intervention, and opioid stewardship. The growing availability of independent medication review services with specific TAC experience provides insurers with enhanced capacity to manage medication-related risk and support better claimant outcomes.